Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China · Delayed Price · Currency is CNY 16.66
+0.11 (0.66%)
Jan 23, 2026, 3:00 PM CST
SHA:688526 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | 459.54 | 382.35 | 395.93 | 409.52 | 570.74 | 447.8 | Upgrade |
Depreciation & Amortization | 109.5 | 109.5 | 114.27 | 97.69 | 62.64 | 37.03 | Upgrade |
Other Amortization | 0.33 | 0.33 | 0.23 | - | - | - | Upgrade |
Loss (Gain) From Sale of Assets | 0.33 | 0.33 | 0.09 | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | 3.31 | 3.31 | 1.72 | -1.29 | 1.57 | 2.43 | Upgrade |
Loss (Gain) From Sale of Investments | -37.6 | -37.6 | -9.34 | -6.65 | -5.13 | -3.98 | Upgrade |
Provision & Write-off of Bad Debts | 11.88 | 11.88 | 84.47 | 23.49 | 7.85 | 8.42 | Upgrade |
Other Operating Activities | -68.03 | -33.46 | -36.09 | -41.45 | -52.19 | -30.49 | Upgrade |
Change in Accounts Receivable | -20.4 | -20.4 | -19.85 | -134.36 | -118.72 | -123.29 | Upgrade |
Change in Inventory | 6.43 | 6.43 | 8.81 | -67.96 | -38.5 | -10.03 | Upgrade |
Change in Accounts Payable | -34.07 | -34.07 | 15.15 | 121.36 | 77.77 | 72.55 | Upgrade |
Change in Other Net Operating Assets | - | - | - | 6.74 | 9.07 | - | Upgrade |
Operating Cash Flow | 435.31 | 392.68 | 538.03 | 423.71 | 531.27 | 400.14 | Upgrade |
Operating Cash Flow Growth | 19.11% | -27.02% | 26.98% | -20.25% | 32.77% | 158.34% | Upgrade |
Capital Expenditures | -120.81 | -106.94 | -104.5 | -102.85 | -374.45 | -111.6 | Upgrade |
Sale of Property, Plant & Equipment | 2.59 | 2.59 | 0.18 | 0.08 | - | 0.03 | Upgrade |
Cash Acquisitions | -4.5 | - | -4.05 | -8.46 | - | - | Upgrade |
Investment in Securities | -328.56 | 161.16 | -281.45 | -582.14 | 12 | -1,097 | Upgrade |
Other Investing Activities | 120.96 | 39.78 | 60.83 | 56.24 | 31.35 | 18.67 | Upgrade |
Investing Cash Flow | -330.32 | 96.59 | -329 | -637.13 | -331.1 | -1,190 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 60 | Upgrade |
Long-Term Debt Issued | - | 97 | 236.5 | 271.5 | 78 | - | Upgrade |
Total Debt Issued | - | 97 | 236.5 | 271.5 | 78 | 60 | Upgrade |
Long-Term Debt Repaid | - | -385.09 | -222.84 | -78.84 | -60.01 | - | Upgrade |
Net Debt Issued (Repaid) | -58.6 | -288.09 | 13.66 | 192.66 | 17.99 | 60 | Upgrade |
Issuance of Common Stock | 17.69 | - | - | 14.84 | 1.86 | 1,158 | Upgrade |
Repurchase of Common Stock | -35.29 | -35.29 | - | - | - | - | Upgrade |
Common Dividends Paid | -199.78 | -204.58 | -97.09 | -93.48 | -136.82 | -0.37 | Upgrade |
Other Financing Activities | 54.48 | 24.79 | -19 | -0.5 | -4.22 | -12.17 | Upgrade |
Financing Cash Flow | -221.51 | -503.18 | -102.43 | 113.52 | -121.18 | 1,206 | Upgrade |
Foreign Exchange Rate Adjustments | -0.02 | 0.02 | 0.05 | - | - | - | Upgrade |
Net Cash Flow | -116.54 | -13.89 | 106.67 | -99.89 | 78.99 | 415.56 | Upgrade |
Free Cash Flow | 314.49 | 285.74 | 433.53 | 320.86 | 156.82 | 288.54 | Upgrade |
Free Cash Flow Growth | 8.72% | -34.09% | 35.12% | 104.60% | -45.65% | 1582.19% | Upgrade |
Free Cash Flow Margin | 31.01% | 30.34% | 40.74% | 32.05% | 14.22% | 34.22% | Upgrade |
Free Cash Flow Per Share | 0.67 | 0.61 | 0.93 | 0.69 | 0.34 | 0.75 | Upgrade |
Cash Income Tax Paid | 93.19 | 109.85 | 98.3 | 96.75 | 86.87 | 97.94 | Upgrade |
Levered Free Cash Flow | 741.81 | 438.28 | 38.93 | 134.02 | -1.1 | 208.51 | Upgrade |
Unlevered Free Cash Flow | 742.12 | 441.27 | 44.03 | 137.43 | 0.04 | 208.77 | Upgrade |
Change in Working Capital | -43.96 | -43.96 | -13.26 | -57.58 | -54.22 | -61.07 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.